Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4230-4237

  Taylor, M A ^a   Chaudhary, P M ^a   Klem, J ^a   Kumar, V ^a   Schatzle, J D ^a   Bennettt, M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EXOCYTOSIS; GENE OVEREXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0035887945     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4230     Document Type: Article

References (64)

1. Biology of natural killer cells
2. Murine natural killer cells and marrow graft rejection
3. In search of the "missing self": MHC molecules and NK cell recognition
4. Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
5. Perforin dependence of natural killer cell-mediated tumor control in vivo
6. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
7. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent
8. Fas-mediated cytotoxicity by freshly isolated natural killer cells
9. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
10. Perforin, Fas ligand, and TNF are the major cytotoxic molecules used by lymphokine-activated killer cells
11. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: Influence of mouse colony environment
12. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice
13. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
14. Molecular cloning and expression of a receptor for human tumor necrosis factor
15. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
16. A death-domain-containing receptor that mediates apoptosis
17. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB
18. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
19. The receptor for the cytotoxic ligand TRAIL
20. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
21. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
22. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
23. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
24. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
25. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
26. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
27. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
28. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal
29. An induced proximity model for caspase-8 activation
30. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
31. Inhibition of death receptor signals by cellular FLIP
32. Casper is a FADD- and caspase-related inducer of apoptosis
33. CASH, a novel caspase homologue with death effector domains
34. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis
35. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
36. The role of c-FLIP in modulation of CD95-induced apoptosis
37. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
38. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
39. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
40. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
41. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
42. Improved methods of retroviral vector transduction and production for gene therapy
43. Production of high-titer helper-free retroviruses by transient transfection
44. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor
45. Molecular determinants of response to TRAIL in killing of normal and cancer cells
46. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
47. Rapid in vivo assay of mouse natural killer cell activity
48. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice
49. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis
50. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
51. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells
52. TNF and lymphotoxin secretion by human NK cells leads to antiviral cytotoxicity
53. Compromised anti-tumor responses in tumor necrosis factor-α knockout mice
54. Stimulation of genetic resistance to marrow grafts in mice by interferon-αβ
55. NK cells activated with IL-2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo
56. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2
57. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-γ production, and expansion of natural killer cells
58. Regulation of interferon-γ production by IL-12 and IL-18
59. The suppressive influences of human TNF on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of TNF and interferon-γ
60. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo
61. Effect of interferon-γ on the susceptibility to Fas(CD95/APO-1)-mediated cell death in human hepatoma cells
62. Natural killer cells and natural killer T cells
63. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells
64. low cells in which anti-TGF-β upmodulates c-kit